IN2013MU01155A - - Google Patents

Info

Publication number
IN2013MU01155A
IN2013MU01155A IN1155MU2013A IN2013MU01155A IN 2013MU01155 A IN2013MU01155 A IN 2013MU01155A IN 1155MU2013 A IN1155MU2013 A IN 1155MU2013A IN 2013MU01155 A IN2013MU01155 A IN 2013MU01155A
Authority
IN
India
Prior art keywords
cyclobenzaprine
salts
composition
pharmaceutical compositions
relates
Prior art date
Application number
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Vivek Dubey
Vishal Omprakash Daga
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060055 priority Critical patent/WO2014167440A1/en
Priority to IN1155MU2013 priority patent/IN2013MU01155A/en
Publication of IN2013MU01155A publication Critical patent/IN2013MU01155A/en

Links

Abstract

The present invention relates to modified release pharmaceutical compositions of cyclobenzaprine or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising unit dosage form of cyclobenzaprine or salts thereof in the form of uncoated units. The composition may provide extended and specific release of cyclobenzaprine or salts thereof to achieve therapeutically effective plasma concentration over a period of 24 hours to treat muscle spasm associated with painful musculoskeletal conditions when administered to a patient in need thereof. The invention also includes process of preparing such composition.
IN1155MU2013 2013-03-26 2014-03-22 IN2013MU01155A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/060055 WO2014167440A1 (en) 2013-03-26 2014-03-22 Modified release pharmaceutical compositions of cyclobenzaprine or salts thereof
IN1155MU2013 IN2013MU01155A (en) 2013-03-26 2014-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1155MU2013 IN2013MU01155A (en) 2013-03-26 2014-03-22

Publications (1)

Publication Number Publication Date
IN2013MU01155A true IN2013MU01155A (en) 2015-04-24

Family

ID=54395429

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1155MU2013 IN2013MU01155A (en) 2013-03-26 2014-03-22

Country Status (1)

Country Link
IN (1) IN2013MU01155A (en)

Similar Documents

Publication Publication Date Title
MX2021000071A (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease.
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
IN2015DN03219A (en)
BR112015022197A8 (en) use of a compound for the manufacture of a medicament or pharmaceutical composition for treating cataplexy
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2015000485A (en) Treatment of multiple sclerosis with combination of laquinimod and fampridine.
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
GB201115977D0 (en) Neurodevelopmental disorders
TW201129361A (en) Methods for treating pain
IN2013MU01155A (en)
MX2016001177A (en) Treatment of multiple sclerosis with combination of laquinimod and flupirtine.
MX2020005438A (en) Abuse deterrent morphine sulfate dosage forms.
IN2013MU01154A (en)
MX2014011843A (en) Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma.
IN2014MU01185A (en)
IN2014MU01184A (en)
IN2013MU01249A (en)
IN2013MU01244A (en)
IN2013MU01250A (en)
IN2013MU01248A (en)
IN2013MU01245A (en)